The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A

Background: Patients with chronic spontaneous urticaria (CSU), an autoimmune disorder, show increased skin expression of IL-17A and can benefit from treatment with the anti-IL-17A biologic secukinumab. The mechanisms that drive IL-17A expression in CSU are currently unknown, but may involve Semaphor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobna, Matanis, Nasren, Eiza, Adi, Sabag, Jacob, Bejar, Maria, Gimenez-Arnau Ana, Marcus, Maurer, Zahava, Vadasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998863/
https://www.ncbi.nlm.nih.gov/pubmed/33801296
http://dx.doi.org/10.3390/biom11030373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998863/
https://www.ncbi.nlm.nih.gov/pubmed/33801296
http://dx.doi.org/10.3390/biom11030373

Ejemplares similares